This post was originally published on this site
Over the past month, the stock has surged 161.9%. Furthermore, AEHR has gained 152.6% year-to-date. The company’s significant advancement in the silicon carbide device market and impressive financial performance have driven the rally.
However, the stock looks significantly overvalued at its current price level. Moreover, given the company’s mixed growth estimates, the stock’s near-term prospects look uncertain.
